Morgan Stanley Call 35 ML 21.03.2.../ DE000MG2F533 /
28/06/2024 13:59:55 | Var.-0.010 | Denaro28/06/2024 | Lettera28/06/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.420EUR | -2.33% | 0.420 Quantità in denaro: 150,000 |
0.430 Quantità in lettera: 150,000 |
Cie Generale des Eta... | 35.00 EUR | 21/03/2025 | Call |
GlobeNewswire
14:18
ECD Auto Design Reports First Quarter 2024 Financial Results; Revenues Increase 207% to Record $8.3 ...
GlobeNewswire
14:17
Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Heal...
GlobeNewswire
14:15
Regency Centers Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
14:08
VCI Global Announces Secondary Listing on the Frankfurt Stock Exchange, Expanding its Market Reach
GlobeNewswire
14:05
Bebe Rexha Returns to Roblox with New Listening Party Through Super League's Innovative Scalable Mus...
GlobeNewswire
14:00
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatme...
GlobeNewswire
14:00
Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide...
GlobeNewswire
14:00
Futureverse and Animoca Brands form strategic partnership with mutual investment to fuel technology ...
GlobeNewswire
14:00
Bitdeer Expands Power Capacity Pipeline to 2.5 GW with 570 MW Strategic Partnership with Monroe Coun...
GlobeNewswire
13:55
Clearmind Medicine Granted Patent Approval in Hong Kong for its Binge Behaviors Treatment